Form D · Biotechnology
Amunix Pharmaceuticals, Inc.
South San Francisco, CA · CIK 0001805035
Offering snapshot reported Mar 9, 2021 · SEC filing
- Reported sold
- $117M Offering amount: $117M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 26, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 9, 2021 | Initial | $116,999,980 | No comparison | 28 | SEC filing |
| Jan 21, 2021 | Initial | $0 | No comparison | 1 | SEC filing |
| Jul 17, 2020 | Initial | $0 | No comparison | 3 | SEC filing |
| Mar 12, 2020 | Initial | $83,590,402 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-391600
Source: Form D, filed Mar 9, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Brush | Director |
| Richard Heyman | Director |
| David Hirsch | Director |
| Trisha Millican | Director |
| Volker Schellenberger | Executive |
| Otello Stampacchia | Director |
| James Topper | Director |
| Angie You | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Tower Pl, #1100
South San Francisco, CA, 94080-1826
South San Francisco, CA, 94080-1826